SYRS - Syros Pharmaceuticals GAAP EPS of $1.30 beats by $2.43 revenue of $2.8M misses by $0.7M
2023-08-08 07:37:47 ET
- Syros Pharmaceuticals press release ( NASDAQ: SYRS ): Q2 GAAP EPS of $1.30 beats by $2.43 .
- Revenue of $2.8M (-55.4% Y/Y) misses by $0.7M .
- Cash, cash equivalents and marketable securities as of June 30, 2023 were $144 million, as compared with $166 million on March 31, 2023.
For further details see:
Syros Pharmaceuticals GAAP EPS of $1.30 beats by $2.43, revenue of $2.8M misses by $0.7M